Key result
Arrhythmogenic cardiomyopathy presents a diagnostic challenge due to its concealed phase and risk of sudden cardiac death, emphasizing the critical role of clinicopathologic evaluation.
This review highlights the evolving understanding of arrhythmogenic cardiomyopathy as a broader spectrum of disease and emphasizes the critical role of pathologists in identifying it to protect at-risk family members.
Raises pathologist vigilance for concealed cases in sudden deaths; extends spectrum concept but leaves diagnostic criteria and prevalence open for validation.
Arrhythmogenic cardiomyopathy (AC) has traditionally been regarded as a rare disease with variably penetrant autosomal-dominant inheritance. Recent years have revealed that AC is actually a spectrum of disease with prevalence much higher than previously thought. Diagnosis can be quite challenging because of highly variable clinical presentation, even among family members sharing a mutation. Unlike other cardiomyopathies, AC has a concealed phase during which patients have arrhythmias in the absence of structural heart disease but remain at risk of sudden cardiac death. Importantly, it is in the setting of sudden cardiac death that pathologists are most likely to encounter AC. It is critical that these findings not be overlooked, as family members of the deceased may also be affected and could potentially avoid such a dismal outcome. With time, advances in ancillary studies are likely to expand the role for pathologists in AC diagnosis.
No takes yet. Share an insight, caveat, or question.
McGregor et al. (2015) conducted a review in Arrhythmogenic cardiomyopathy. Arrhythmogenic cardiomyopathy presents a diagnostic challenge due to its concealed phase and risk of sudden cardiac death, emphasizing the critical role of clinicopathologic evaluation.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: